Oncology & Cancer

New treatment approved for common skin cancer

(HealthDay)—Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat advanced squamous cell carcinoma (CSCC), the agency said in a news release.

Oncology & Cancer

Review: Treatments for primary basal cell carcinoma compared

(HealthDay)—For patients with primary basal cell carcinoma (BCC), estimated recurrence rates are similarly low for excision, Mohs surgery, curettage and diathermy, and external-beam radiation, according to a review and ...

Oncology & Cancer

MicroRNAs predict recurrence risk of head and neck tumors

A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours. As part of a large-scale study, the authors constructed ...

page 37 from 40